- Home
- VMO vs EBS Comparison
VMO vs EBS Comparison
Compare VMO & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMO
- EBS
- Stock Information
- Founded
- VMO 1992
- EBS 1998
- Country
- VMO United States
- EBS United States
- Employees
- VMO N/A
- EBS 1600
- Industry
- VMO Trusts Except Educational Religious and Charitable
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- VMO Finance
- EBS Health Care
- Exchange
- VMO Nasdaq
- EBS Nasdaq
- Market Cap
- VMO 644.7M
- EBS 631.8M
- IPO Year
- VMO N/A
- EBS 2006
- Fundamental
- Price
- VMO $9.74
- EBS $11.37
- Analyst Decision
- VMO
- EBS Strong Buy
- Analyst Count
- VMO 0
- EBS 3
- Target Price
- VMO N/A
- EBS $14.33
- AVG Volume (30 Days)
- VMO 254.7K
- EBS 1.1M
- Earning Date
- VMO 01-01-0001
- EBS 03-04-2025
- Dividend Yield
- VMO 4.39%
- EBS N/A
- EPS Growth
- VMO N/A
- EBS N/A
- EPS
- VMO N/A
- EBS N/A
- Revenue
- VMO N/A
- EBS $1,125,500,000.00
- Revenue This Year
- VMO N/A
- EBS $6.26
- Revenue Next Year
- VMO N/A
- EBS $2.42
- P/E Ratio
- VMO N/A
- EBS N/A
- Revenue Growth
- VMO N/A
- EBS 2.05
- 52 Week Low
- VMO $7.86
- EBS $1.42
- 52 Week High
- VMO $9.87
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- VMO 51.03
- EBS 67.39
- Support Level
- VMO $9.48
- EBS $9.84
- Resistance Level
- VMO $9.77
- EBS $11.98
- Average True Range (ATR)
- VMO 0.07
- EBS 0.62
- MACD
- VMO 0.02
- EBS 0.19
- Stochastic Oscillator
- VMO 87.93
- EBS 76.98
About VMO Invesco Municipal Opportunity Trust
Invesco Municipal Opportunity Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.